Mitochondrial Biology Unit, The MRC and University of Cambridge, Cambridge CB2 0XY, UK.
Department of Neurosciences, University of Padova, 35128 Padova, Italy.
Int J Mol Sci. 2021 Jan 8;22(2):586. doi: 10.3390/ijms22020586.
Mitochondria are ubiquitous intracellular organelles found in almost all eukaryotes and involved in various aspects of cellular life, with a primary role in energy production. The interest in this organelle has grown stronger with the discovery of their link to various pathologies, including cancer, aging and neurodegenerative diseases. Indeed, dysfunctional mitochondria cannot provide the required energy to tissues with a high-energy demand, such as heart, brain and muscles, leading to a large spectrum of clinical phenotypes. Mitochondrial defects are at the origin of a group of clinically heterogeneous pathologies, called mitochondrial diseases, with an incidence of 1 in 5000 live births. Primary mitochondrial diseases are associated with genetic mutations both in nuclear and mitochondrial DNA (mtDNA), affecting genes involved in every aspect of the organelle function. As a consequence, it is difficult to find a common cause for mitochondrial diseases and, subsequently, to offer a precise clinical definition of the pathology. Moreover, the complexity of this condition makes it challenging to identify possible therapies or drug targets.
线粒体是普遍存在于几乎所有真核生物中的细胞内细胞器,参与细胞生命的各个方面,其主要作用是产生能量。随着人们发现线粒体与各种疾病(包括癌症、衰老和神经退行性疾病)有关,人们对这种细胞器的兴趣越来越浓厚。事实上,功能失调的线粒体无法为心脏、大脑和肌肉等高能量需求的组织提供所需的能量,导致出现了一系列广泛的临床表型。线粒体缺陷是一组临床异质性疾病(称为线粒体疾病)的根源,其发病率为每 5000 例活产儿中有 1 例。原发性线粒体疾病与核 DNA(nDNA)和线粒体 DNA(mtDNA)中的基因突变有关,这些基因突变影响与细胞器功能的各个方面有关的基因。因此,很难找到线粒体疾病的共同病因,从而难以对该疾病进行精确的临床定义。此外,这种疾病的复杂性使得确定可能的治疗方法或药物靶点变得具有挑战性。